Health Catalyst (HCAT) Receivables (2018 - 2026)

Health Catalyst has reported Receivables for 9 years, with the latest figure at $65.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 8.5% year-over-year to $65.6 million; the trailing twelve-month figure through Mar 2026 stood at $65.6 million (down 8.5% YoY), and the FY2025 full-year result was $69.2 million, changed 0.36% from the prior year.
• Receivables for Q1 2026 stood at $65.6 million, down from $69.2 million in the prior quarter.
• The five-year high for Receivables was $77.1 million in Q2 2025, with the low at $43.3 million in Q1 2022.
• Historically, Receivables has averaged $60.1 million across 5 years, with a median of $61.4 million in 2024.
• Annual changes were most pronounced in 2023 — Receivables surged 46.7% — and 2024, when it decreased 9.74%.
• Health Catalyst's Receivables stood at $48.9 million in 2022, then jumped by 32.99% to $65.0 million in 2023, then grew by 6.14% to $69.0 million in 2024, then increased by 0.36% to $69.2 million in 2025, then retreated by 5.17% to $65.6 million in 2026.
• The last three Receivables figures came in at $65.6 million (Q1 2026), $69.2 million (Q4 2025), and $68.6 million (Q3 2025), per Business Quant data.